These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6492074)
21. Influence of alkyl chain ramification on estradiol receptor binding affinity and intrinsic activity of 1,2-dialkylated 1,2-bis(4- or 3-hydroxyphenyl)ethane estrogens and antiestrogens. Hartmann RW J Med Chem; 1986 Sep; 29(9):1668-74. PubMed ID: 3018243 [TBL] [Abstract][Full Text] [Related]
22. 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. Schneider MR; von Angerer E; Schönenberger H; Michel RT; Fortmeyer HP J Med Chem; 1982 Sep; 25(9):1070-7. PubMed ID: 6813499 [TBL] [Abstract][Full Text] [Related]
23. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Verdeal K; Brown RR; Richardson T; Ryan DS J Natl Cancer Inst; 1980 Feb; 64(2):285-90. PubMed ID: 6766510 [TBL] [Abstract][Full Text] [Related]
24. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Kranzfelder G; Hartmann RW; von Angerer E; Schönenberger H; Bogden AE J Cancer Res Clin Oncol; 1982; 103(2):165-80. PubMed ID: 6284766 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, receptor binding, and target-tissue uptake of carbon-11 labeled carbamate derivatives of estradiol and hexestrol. Ouellet R; Rousseau J; Brasseur N; van Lier JE; Diksic M; Westera G J Med Chem; 1984 Apr; 27(4):509-13. PubMed ID: 6323712 [TBL] [Abstract][Full Text] [Related]
26. Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity. Jones CD; Jevnikar MG; Pike AJ; Peters MK; Black LJ; Thompson AR; Falcone JF; Clemens JA J Med Chem; 1984 Aug; 27(8):1057-66. PubMed ID: 6431104 [TBL] [Abstract][Full Text] [Related]
27. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat. Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985 [TBL] [Abstract][Full Text] [Related]
28. 2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds. von Angerer E; Prekajac J J Med Chem; 1983 Jan; 26(1):113-6. PubMed ID: 6402593 [TBL] [Abstract][Full Text] [Related]
29. Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes. Hartmann RW; Kranzfelder G; von Angerer E; Schönenberger H J Med Chem; 1980 Aug; 23(8):841-8. PubMed ID: 7401112 [TBL] [Abstract][Full Text] [Related]
30. Mammary tumor inhibiting effect of 3,3'-diacetoxy-alpha, beta-dialkylstilbenes and of related stilbene oxides. Schneider MR; Schönenberger H; Michel RT; Fortmeyer HP J Med Chem; 1982 Feb; 25(2):141-5. PubMed ID: 7057418 [TBL] [Abstract][Full Text] [Related]
31. [Properties of alkylating derivatives of estrogens]. Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335 [TBL] [Abstract][Full Text] [Related]
32. Effect of N,N'-diethyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines on the 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma of the rat. von Angerer E J Med Chem; 1982 Nov; 25(11):1374-7. PubMed ID: 6815325 [TBL] [Abstract][Full Text] [Related]
34. 2-Arylindenes and 2-arylindenones: molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor. Anstead GM; Wilson SR; Katzenellenbogen JA J Med Chem; 1989 Sep; 32(9):2163-71. PubMed ID: 2769689 [TBL] [Abstract][Full Text] [Related]
35. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor. Borgna JL; Scali J Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844 [TBL] [Abstract][Full Text] [Related]
36. N,N'-Dialkylbis(dichlorophenyl)ethylenediamines and -imidazolidines: relationship between structure and estradiol receptor affinity. von Angerer E; Kranzfelder G; Taneja AK; Schönenberger H J Med Chem; 1980 Dec; 23(12):1347-50. PubMed ID: 7452688 [TBL] [Abstract][Full Text] [Related]
37. Platinum complexes with binding affinity for the estrogen receptor. Knebel N; von Angerer E J Med Chem; 1988 Sep; 31(9):1675-9. PubMed ID: 3411596 [TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity. Murphy CS; Parker CJ; McCague R; Jordan VC Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879 [TBL] [Abstract][Full Text] [Related]
39. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830 [TBL] [Abstract][Full Text] [Related]
40. Catechol estrogens of the 1,1,2-triphenylbut-1-ene type: relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities. Schneider MR; Ball H; Schiller CD J Med Chem; 1986 Aug; 29(8):1355-62. PubMed ID: 3016262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]